TCM Biotech International Corp. (TPE:4169)

TCM Biotech International Revenue

TCM Biotech International had revenue of 172.89M TWD in the quarter ending March 31, 2026, with 0.58% growth. This brings the company's revenue in the last twelve months to 703.09M, up 7.04% year-over-year. In the year 2025, TCM Biotech International had annual revenue of 685.49M with 2.84% growth.

• Revenue (ttm): 703.09M
• Revenue Growth: +7.04%
• P/S Ratio: 15.20
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 10.69B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	685.49M	18.96M	2.84%
Dec 31, 2024	666.53M	-303.09M	-31.26%
Dec 31, 2023	969.62M	167.20M	20.84%
Dec 31, 2022	802.42M	100.38M	14.30%
Dec 31, 2021	702.05M	-35.03M	-4.75%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 29, 2026

Data Sources Report a data error